The selective inhibition of IDO reversed ICV-STZ-induced depression-like behaviors by ameliorating neuroprotective branch deficits in the PrL and inhibiting neurotoxicogenic branch overactivation in the IL. This evidence concerns the gene IDO1 and major depressive disorder.